166 related articles for article (PubMed ID: 10845424)
1. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors.
Chen F; Chang D; Goh M; Klibanov SA; Ljungman M
Cell Growth Differ; 2000 May; 11(5):239-46. PubMed ID: 10845424
[TBL] [Abstract][Full Text] [Related]
2. Proteasome-dependent regulation of p21WAF1/CIP1 expression.
Blagosklonny MV; Wu GS; Omura S; el-Deiry WS
Biochem Biophys Res Commun; 1996 Oct; 227(2):564-9. PubMed ID: 8878553
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
[TBL] [Abstract][Full Text] [Related]
4. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
[TBL] [Abstract][Full Text] [Related]
5. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors.
Kim OH; Lim JH; Woo KJ; Kim YH; Jin IN; Han ST; Park JW; Kwon TK
Int J Oncol; 2004 Apr; 24(4):935-41. PubMed ID: 15010833
[TBL] [Abstract][Full Text] [Related]
6. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
Wagenknecht B; Hermisson M; Eitel K; Weller M
Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
[TBL] [Abstract][Full Text] [Related]
8. Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells.
Kim HD; Tomida A; Ogiso Y; Tsuruo T
J Cell Physiol; 1999 Jul; 180(1):97-104. PubMed ID: 10362022
[TBL] [Abstract][Full Text] [Related]
9. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
Cory AH; Cory JG
Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.
Gaedicke S; Firat-Geier E; Constantiniu O; Lucchiari-Hartz M; Freudenberg M; Galanos C; Niedermann G
Cancer Res; 2002 Dec; 62(23):6901-8. PubMed ID: 12460905
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression.
Seewaldt VL; Dietze EC; Johnson BS; Collins SJ; Parker MB
Cell Growth Differ; 1999 Jan; 10(1):49-59. PubMed ID: 9950218
[TBL] [Abstract][Full Text] [Related]
12. Intracellular localization of p53 tumor suppressor protein in gamma-irradiated cells is cell cycle regulated and determined by the nucleus.
Komarova EA; Zelnick CR; Chin D; Zeremski M; Gleiberman AS; Bacus SS; Gudkov AV
Cancer Res; 1997 Dec; 57(23):5217-20. PubMed ID: 9393737
[TBL] [Abstract][Full Text] [Related]
13. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated.
McKenzie PP; Guichard SM; Middlemas DS; Ashmun RA; Danks MK; Harris LC
Clin Cancer Res; 1999 Dec; 5(12):4199-207. PubMed ID: 10632361
[TBL] [Abstract][Full Text] [Related]
14. The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
Mugita N; Honda Y; Nakamura H; Fujiwara T; Tanaka K; Omura S; Shimbara N; Ogawa M; Saya H; Nakao M
Int J Mol Med; 1999 Feb; 3(2):127-37. PubMed ID: 9917519
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells.
Naujokat C; Sezer O; Zinke H; Leclere A; Hauptmann S; Possinger K
Eur J Haematol; 2000 Oct; 65(4):221-36. PubMed ID: 11073163
[TBL] [Abstract][Full Text] [Related]
16. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21.
Cayrol C; Ducommun B
Oncogene; 1998 Nov; 17(19):2437-44. PubMed ID: 9824154
[TBL] [Abstract][Full Text] [Related]
17. The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67.
Wu Y; Luo H; Kanaan N; Wu J
J Cell Biochem; 2000 Jan; 76(4):596-604. PubMed ID: 10653979
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53.
Li JN; Gorospe M; Chrest FJ; Kumaravel TS; Evans MK; Han WF; Pizer ES
Cancer Res; 2001 Feb; 61(4):1493-9. PubMed ID: 11245456
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation.
An WG; Chuman Y; Fojo T; Blagosklonny MV
Exp Cell Res; 1998 Oct; 244(1):54-60. PubMed ID: 9770348
[TBL] [Abstract][Full Text] [Related]
20. Neocarzinostatin induces an effective p53-dependent response in human papillomavirus-positive cervical cancer cells.
BaƱuelos A; Reyes E; Ocadiz R; Alvarez E; Moreno M; Monroy A; Gariglio P
J Pharmacol Exp Ther; 2003 Aug; 306(2):671-80. PubMed ID: 12750435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]